Clinical Handbook of SchizophreniaKim T. Mueser, Dilip V. Jeste Reviewing the breadth of current knowledge on schizophrenia, this handbook provides clear, practical guidelines for effective assessment and treatment in diverse contexts. Leading authorities have contributed 61 concise chapters on all aspects of the disorder and its clinical management. In lieu of exhaustive literature reviews, each chapter summarizes the state of the science; highlights key points the busy practitioner needs to know; and lists recommended resources, including seminal research studies, invaluable clinical tools, and more. Comprehensive, authoritative, and timely, the volume will enable professionals in any setting to better understand and help their patients or clients with severe mental illness. |
Contents
3 | |
14 | |
25 | |
35 | |
Neuropathology | 44 |
Genetics | 55 |
Environmental Pre and Perinatal Influences in Etiology | 65 |
Psychosocial Factors | 74 |
Assertive Community Treatment | 329 |
Emergency Inpatient and Residential Treatment | 339 |
Treatment in Jails and Prisons | 354 |
FirstEpisode Psychosis | 367 |
Treatment of the Schizophrenia Prodrome | 380 |
Older Individuals | 390 |
Understanding and Working with Aggression Violence | 398 |
Housing Instability and Homelessness | 411 |
Psychopathology | 82 |
Cognitive Functioning | 91 |
Course and Outcome | 100 |
Diagnostic Interviewing | 117 |
Assessment of CoOccurring Disorders | 125 |
Assessment of Psychosocial Functioning | 135 |
Treatment Planning | 145 |
Antipsychotics | 159 |
Side Effects of Antipsychotics | 168 |
Clozapine | 178 |
Other Medications | 186 |
Electroconvulsive Therapy | 196 |
Environmental Supports | 207 |
Family Intervention | 214 |
CognitiveBehavioral Therapy | 226 |
Social Skills Training | 240 |
Cognitive Rehabilitation | 249 |
Vocational Rehabilitation | 261 |
Illness SelfManagement Training | 268 |
Group Therapy | 279 |
Supported Housing | 287 |
SelfHelp Activities | 298 |
Clinical Case Management | 309 |
StrengthsBased Case Management | 319 |
Medical Comorbidity | 424 |
Intellectual Disability and Other Neuropsychiatric Populations | 437 |
Trauma and Posttraumatic Stress Syndromes | 447 |
Management of CoOccurring Substance Use Disorders | 459 |
Parenting | 471 |
Children and Adolescents | 481 |
Suicide | 491 |
The Economics of Schizophrenia | 507 |
Involuntary Commitment | 516 |
Jail Diversion | 524 |
Stigma | 533 |
EvidenceBased Practices | 541 |
Schizophrenia in Developing Countries | 549 |
Remission | 559 |
Recovery | 566 |
Gender | 575 |
Quality of Life | 581 |
Spirituality and Religion | 592 |
Sexuality | 604 |
Schizophrenia in African Americans | 616 |
Ethics | 624 |
631 | |
Other editions - View all
Common terms and phrases
African Americans American Psychiatric Association antipsychotic medications approach aripiprazole assertive community treatment assessment associated atypical antipsychotics behavior brain clients clinical clinicians clozapine cognitive comorbid deficits depression diabetes diagnosis disabilities disease dopamine dose episode evidence evidence-based experiences functioning genes genetic goals guidelines hallucinations haloperidol homeless hospital impairment improve increased individuals with schizophrenia inpatient jail Journal of Psychiatry ment mental disorders mental health mental health services mental illness Mueser negative symptoms olanzapine onset outcomes patients with schizophrenia persons with schizophrenia phrenia population positive symptoms practice problems programs psychiatric psychosis psychosocial psychotic symptoms PTSD quetiapine rates recovery reduce REFERENCES AND RECOMMENDED rehabilitation relapse risk factors risk for suicide risperidone role schizo schizoaffective disorder schizophre severe mental illness sexual side effects skills training specific stigma strategies studies substance abuse supported housing therapy tion trauma treatment of schizophrenia treatment plan typical antipsychotics ziprasidone
Popular passages
Page v - The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) jointly support this cooperative research planning conference project.